Neurotech poised to commence clinical trials in March quarter
Finfeed
Archived
Dec 16, 2020
Neurotech International Limited (ASX:NTI) has commenced a stage 1 clinical product formulation and development studies and anticipates entering clinical trials in the March quarter next year.
